SCHEMBL108916

SCHEMBL108916

CCC(O)CCc1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP2A6 P11509 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
PTGFR P43088 1/20 0.41
IGF1R P08069 1/20 0.40
ALOX15 P16050 1/20 0.40
MMP12 P39900 4/20 0.40
MMP13 P45452 4/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP14 P50281 1/20 0.40
STAT3 P40763 1/20 0.40
IDO1 P14902 1/20 0.38
DPP4 P27487 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
KCNH2 Q12809 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
FFAR1 O14842 1/20 0.37
LPL P06858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5950465 0.91 MMP12 (0.44) MMP12MMP13MMP2MMP9MMP14
SCHEMBL27325037 0.89 CYP1A2 (0.50) CYP1A2CYP2A6TAAR1PTGFRIGF1R
SCHEMBL28411255 0.88 IGF1R (0.46) CYP1A2CYP2A6TAAR1IGF1RALOX15
SCHEMBL1462321 0.86 CYP1A2 (0.43) CYP1A2CYP2A6TAAR1PTGFRIGF1R
SCHEMBL19321715 0.83 CYP1A2 (0.45) CYP1A2CYP2A6TAAR1PTGFRIGF1R
SCHEMBL11471420 0.83 CYP1A2 (0.45) CYP1A2CYP2A6TAAR1PTGFRIGF1R
SCHEMBL107785 0.83 ESR1 (0.52) CYP1A2TAAR1ALOX15DPP4TDP1
SCHEMBL27547657 0.83 TAAR1 (0.45) TAAR1KCNH2TDP1L3MBTL1
SCHEMBL19321712 0.83 CYP1A2 (0.45) CYP1A2CYP2A6TAAR1PTGFRIGF1R
SCHEMBL10247192 0.82 CYP1A2 (0.43) CYP1A2CYP2A6TAAR1PTGFRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
EP-3519567-A1 ENGINEERED MICROORGANISMS FOR PRODUCTION OF COMMODITY CHEMICALS AND CELLULAR BIOMASS The Regents of The University of California (US) 2019-08-07 EP disclosed
WO-2018151833-A1 HIGH PRESSURE ZONE FORMATION FOR PRETREATMENT SWEETWATER ENERGY, INC. (US) 2018-08-23 WO disclosed
WO-2018067458-A1 ENGINEERED MICROORGANISMS FOR PRODUCTION OF COMMODITY CHEMICALS AND CELLULAR BIOMASS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-04-12 WO disclosed
EP-3230463-A1 RAPID PRETREATMENT Sweetwater Energy, Inc. (US) 2017-10-18 EP disclosed
WO-2016094594-A1 RAPID PRETREATMENT SWEETWATER ENERGY, INC. (US) 2016-06-16 WO disclosed
WO-2015179243-A1 SUGAR SEPARATION AND PURIFICATION THROUGH FILTRATION SWEETWATER ENERGY, INC. (US) 2015-11-26 WO disclosed
EP-2836602-A1 METHODS AND SYSTEMS FOR SACCHARIFICATION OF BIOMASS Sweetwater Energy, Inc. (US) 2015-02-18 EP disclosed
WO-2014026154-A1 OPTIMIZED PRETREATMENT OF BIOMASS SWEETWATER ENERGY, INC. (US) 2014-02-13 WO disclosed
WO-2013155496-A1 METHODS AND SYSTEMS FOR SACCHARIFICATION OF BIOMASS SWEETWATER ENERGY, INC. (US) 2013-10-17 WO disclosed
WO-2011081658-A2 METHODS AND COMPOSITIONS FOR PRODUCING CHEMICAL PRODUCTS FROM C. PHYTOFERMENTANTS QTEROS, INC. (US) 2011-07-07 WO disclosed
WO-2010127182-A1 ADAPTING MICROORGANISMS FOR AGRICULTURAL PRODUCTS EVOLUGATE, LLC (US) 2010-11-04 WO disclosed
EP-2245162-A2 ISOLATED ALCOHOL DEHYDROGENASE ENZYMES AND USES THEREOF Bio Architecture Lab, Inc. (US) 2010-11-03 EP disclosed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP disclosed
WO-2009097346-A2 ISOLATED ALCOHOL DEHYDROGENASE ENZYMES AND USES THEREOF BIO ARCHITECTURE LAB, INC. (US) 2009-08-06 WO disclosed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
US-20080194565-A1 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2008-08-14 US disclosed
US-3994921-A COLORING PLASTICS AND LACQUERS YELLOW CIBA-GEIGY CORPORATION (US) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194565-A1 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases F2RL3, ACOX3, LPAR5 CYP1A2 1392/4885CYP2A6 547/4885TAAR1 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.